KraneShares MSCI All China Health Care Index ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KURE and other ETFs, options, and stocks.

About KURE

KURE tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. 

Index-Tracked
MSCI China All Shares HC 10/40 NR USD
Index-TrackedMSCI China All Shares HC 10/40 NR USD
Category
China Region
CategoryChina Region
Number of holdings
74
Number of holdings74
Inception Date
Jan 31, 2018
Inception DateJan 31, 2018

What's in this fund

Sectors

As of April 15, 2024
Healthcare98.26%
Consumer Defensive1.09%
Basic Materials0.65%

Top 10 Holdings (41.33% of total assets)

As of April 15, 2024
NameSymbol% Assets
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A300760 (XSHE)8.07%
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A600276 (XSHG)6.82%
BeiGene Ltd Ordinary Shares06160 (XHKG)4.17%
CSPC Pharmaceutical Group Ltd01093 (XHKG)3.91%
WuXi Biologics (Cayman) Inc02269 (XHKG)3.85%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A600436 (XSHG)3.35%
Innovent Biologics Inc01801 (XHKG)3.14%
Aier Eye Hospital Group Co Ltd Class A300015 (XSHE)2.85%
Wuxi AppTec Co Ltd Class A603259 (XSHG)2.70%
Chongqing Zhifei Biological Products Co Ltd Class A300122 (XSHE)2.47%

KURE Key Statistics

AUM
44.64M
AUM44.64M
Price-Earnings ratio
25.89
Price-Earnings ratio25.89
30-Day yield
30-Day yield
Average volume
7.61K
Average volume7.61K
High today
$13.86
High today$13.86
Low today
$13.76
Low today$13.76
Open price
$13.76
Open price$13.76
Volume
1.72K
Volume1.72K
52 Week high
$21.49
52 Week high$21.49
52 Week low
$13.60
52 Week low$13.60
Expense ratio
0.79
Expense ratio0.79

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.